HER2-positive Recurrent/Metastatic Breast Cancer
2 clinical trials · Condition
◉ Watch HER2-positive Recurrent/Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT05252546) | Jiangsu HengRui Medicine Co., Ltd. | 2022-03-08 |
Track HER2-positive Recurrent/Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.